Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Heron Therapeutics Inc HRTX

Healthcare Biotechnology
Heron Therapeutics, Inc. is a commercial-stage biotechnology company. The Company commercializes a portfolio of products to care for acute care and oncology patients. Its oncology care product portfolio includes SUSTOL and CINVANTI. SUSTOL is used for the prevention of acute and delayed nausea and vomiting associated with both moderately emetogenic chemotherapy (MEC), and anthracycline and... see more

Recent & Breaking News (NDAQ:HRTX)

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Heron Therapeutics, Inc. To Contact The Firm

Press Releases July 22, 2019

CLASS ACTION UPDATE for LTHM, HRTX and BOX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Press Releases July 22, 2019

UPCOMING DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Heron Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

GlobeNewswire July 22, 2019

Heron Therapeutics, Inc. (HRTX), Beazer Homes USA, Inc. (BZH) & Ascena Retail Group, Inc. (ASNA) - Bronstein, Gewirtz & Grossman, LLC Class Action Reminder

Press Releases July 22, 2019

FILING DEADLINE - Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of LTHM, HRTX and ASNA

Press Releases July 21, 2019

ROSEN, A TOP RANKED LAW FIRM, Reminds Heron Therapeutics, Inc. Investors of Important August 5th Deadline in the Securities Class Action - HRTX

GlobeNewswire July 20, 2019

SHAREHOLDER ALERT: BE HRTX DBD: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Press Releases July 19, 2019

CLASS ACTION UPDATE for HRTX, CLDR and BUD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Press Releases July 19, 2019

Metro Bank PLC (MBNKF), Heron Therapeutics, Inc. (HRTX) & Beazer Homes USA, Inc. (BZH) - Bronstein, Gewirtz & Grossman, LLC Class Action Update

GlobeNewswire July 19, 2019

SHAREHOLDER ALERT: HL HRTX CLDR: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Press Releases July 19, 2019

Metro Bank PLC (MBNKF), Heron Therapeutics, Inc. (HRTX) & Beazer Homes USA, Inc. (BZH) - Bronstein, Gewirtz & Grossman, LLC Class Action

Press Releases July 19, 2019

CLASS ACTION UPDATE for LTHM, HRTX and RMED: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Press Releases July 18, 2019

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Heron Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - HRTX

Press Releases July 18, 2019

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Heron Therapeutics, Inc. To Contact The Firm

Press Releases July 18, 2019

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of HRTX, EROS and RBGLY

Press Releases July 17, 2019

FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of HRTX, PVTL and ZUO

Press Releases July 17, 2019

Metro Bank PLC (MBNKF), Heron Therapeutics, Inc. (HRTX) & Beazer Homes USA, Inc. (BZH) - Bronstein, Gewirtz & Grossman, LLC Class Action Reminder

Press Releases July 17, 2019

CLASS ACTION UPDATE for HRTX, PVTL, RMED and ZUO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

GlobeNewswire July 17, 2019

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Heron Therapeutics, Box, Cloudera, and Mammoth Energy and Encourages Investors to Contact the Firm

GlobeNewswire July 16, 2019

SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Heron Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - HRTX

GlobeNewswire July 16, 2019